
Keywords: T2DM; type 2 diabetes mellitus; PON; paraoxonase; Hmgcr; hepatic 3-hydroxy-3-methylglutaryl-CoA reductase; Scarb1; scavenger receptor class B member 1; Ahr; aryl hydrocarbon receptor; Lipc; hepatic Lipase; Lcat; lecithin-cholesterol acyltransferase; VLDL;